CD33 and myeloid sarcoma: Possible reasons for the observed discrepancy between the studies may include relatively limited sample sizes and statistical power in both our study and that of Siokas et al. [19], inter-population variation in rs3865444 allele frequencies, differences in linkage disequilibrium between the studied SNP and other functional CD33 variants, differences in MS/control selection criteria, and others [56].